Vancomycin trough concentrations in overweight or obese pediatric patients

Pharmacotherapy

Volumn 33, Issue 12, 2013, Pages 1273-1277

  Heble Jr , Daniel E ^a   McPherson, Christopher ^b   Nelson, Miranda P ^b,c   Hunstad, David A ^d  

^a CHILDREN S MERCY HOSPITAL   (United States)

^b ST LOUIS CHILDREN S HOSPITAL   (United States)

^c SOUTHERN ILLINOIS UNIVERSITY EDWARDSVILLE   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

obese; overweight; pediatrics; therapeutic drug monitoring; vancomycin

Indexed keywords

VANCOMYCIN;

ADOLESCENT; ADULT; ARTICLE; BODY WEIGHT; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; MALE; OBESITY; OBSERVATIONAL STUDY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; STEADY STATE; YOUNG ADULT;

OBESE; OVERWEIGHT; PEDIATRICS; THERAPEUTIC DRUG MONITORING; VANCOMYCIN;

ADOLESCENT; ALGORITHMS; ANTI-BACTERIAL AGENTS; BODY WEIGHT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; MALE; OBESITY; OVERWEIGHT; RETROSPECTIVE STUDIES; VANCOMYCIN;

EID: 84899115859     PISSN: 02770008     EISSN: 18759114     Source Type: Journal    
DOI: 10.1002/phar.1321     Document Type: Article

References (16)

1. Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM,. Prevalence of high body mass index in US children and adolescents, 2007-2008. JAMA 2010; 303: 242-9.
2. Rybak M, Lomaestro B, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 2009; 66: 82-98.
3. Grace E,. Altered vancomycin pharmacokinetics in obese and morbidly obese patients: what we have learned over the past 30 years. J Antimicrob Chemother 2012; 67: 1305-10.
4. Reynolds DC, Waite LH, Alexander DP, DeRyke CA,. Performance of a vancomycin dosage regimen developed for obese patients. Am J Health Syst Pharm 2012; 69: 944-50.
5. Frymoyer A, Hersh AL, Benet LZ, Guglielmo BJ,. Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate. Pediatr Infect Dis J 2009; 28: 398-402.
6. Frymoyer A, Hersh AL, Coralic Z, Benet LZ, Joseph Guglielmo B,. Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: a Monte Carlo simulation. Clin Ther 2010; 32: 534-42.
7. Nelson MP, Pridgen A, D'Anna EK, et al. Age-stratified empiric vancomycin dosing and trough targets in children [abstract]. 50th Interscience Conference on Antimicrobial Agents and Chemotherapy. 2010: G1-909.
8. Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC growth charts for the United States: methods and development. Vital Health Stat 11 2002;(246): 1-190.
9. Moffett BS, Kim S, Edwards MS,. Vancomycin dosing in obese pediatric patients. Clin Pediatr (Phila) 2011; 50: 442-6.
10. Miller M, Miller JL, Hagemann TM, Harrison D, Chavez-Bueno S, Johnson PN,. Vancomycin dosage in overweight and obese children. Am J Health Syst Pharm 2011; 68: 2062-8.
11. McKamy S, Hernandez E, Jahng M, Moriwaki T, Deveikis A, Le J,. Incidence and risk factors influencing the development of vancomycin nephrotoxicity in children. J Pediatr 2011; 158: 422-6.
12. Sakoulas G, Gold HS, Cohen RA, Venkataraman L, Moellering RC, Eliopoulos GM,. Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia. J Antimicrob Chemother 2006; 57: 699-704.
13. Le J, Bradley JS, Murray W, et al. Improved vancomycin dosing in children using area under the curve exposure. Pediatr Infect Dis J 2013; 32: e155-63.
14. Eiland LS, English TM, Eiland EH III,. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients. Ann Pharmacother 2011; 45: 582-9.
15. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin- resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52: e18-55.
16. Frymoyer A, Guglielmo BJ, Wilson SD, Scarpace SB, Benet LZ, Hersh AL,. Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations. Pharmacotherapy 2011; 31: 871-6.